The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.
  • Ticker

RNS




AstraZeneca PLC - AZN FDA accepts sBLA file for Imfinzi; priority review
07:00 17-Oct-2017  RNS  0.27% View chart
AstraZeneca PLC - AZN FDA grants Tagrisso BTD for 1st-line EGFR nsclc
07:00 09-Oct-2017  RNS  0.27% View chart
AstraZeneca PLC - AZN Aspen acquires remaining rights to AZ anaesthetics
07:00 14-Sep-2017  RNS  0.27% View chart
AstraZeneca PLC - AZN IMFINZI superior PFS in Stage III lung cancer
07:00 11-Sep-2017  RNS  0.27% View chart
AstraZeneca PLC - AZN Tagrisso potential standard of care in lung cancer
07:00 11-Sep-2017  RNS  0.27% View chart
AstraZeneca PLC - AZN Celgene and AZ update on Fusion trial programme
12:39 07-Sep-2017  RNS  0.27% View chart
AstraZeneca PLC - AZN AZ tezepelumab cuts exacerbations in severe asthma
07:00 07-Sep-2017  RNS  0.27% View chart
AstraZeneca PLC - AZN AZ Duaklir improves lung function in COPD patients
07:00 07-Sep-2017  RNS  0.27% View chart
AstraZeneca PLC - AZN Directorate Change
07:00 05-Sep-2017  RNS  0.27% View chart
AstraZeneca PLC - AZN Faslodex gets US FDA OK for expanded use in breast
07:00 29-Aug-2017  RNS  0.27% View chart
AstraZeneca PLC - AZN Lynparza gets broad FDA approval in ovarian cancer
07:00 18-Aug-2017  RNS  0.27% View chart
AstraZeneca PLC - AZN Directorate Change
07:00 16-Aug-2017  RNS  0.27% View chart
AstraZeneca PLC - AZN Publication of a Prospectus
13:30 10-Aug-2017  RNS  0.27% View chart
AstraZeneca PLC - AZN AZ acalabrutinib submission accepted by US FDA
07:00 02-Aug-2017  RNS  0.27% View chart
AstraZeneca PLC - AZN BTD for AZ's acalabrutinib in mantle cell lymphoma
07:00 01-Aug-2017  RNS  0.27% View chart
AstraZeneca PLC - AZN Imfinzi granted BTD by US FDA for Stage III nsclc
07:00 31-Jul-2017  RNS  0.27% View chart
AstraZeneca PLC - AZN Tagrisso significantly improves FLAURA
07:15 27-Jul-2017  RNS  0.27% View chart
AstraZeneca PLC - AZN AZ reports initial results from MYSTIC lung trial
07:11 27-Jul-2017  RNS  0.27% View chart
AstraZeneca PLC - AZN AZ & MERCK ESTABLISH STRATEGIC ONCOLOGY DEAL
07:06 27-Jul-2017  RNS  0.27% View chart
AstraZeneca PLC - AZN AstraZeneca PLC - H1 2017 Results
07:00 27-Jul-2017  RNS  0.27% View chart

 Page 1 of 2

| 1 | 2 | Next



RNS - regulatory news service - home


MARKET NEWS – SEARCH FEATURES

Market News is the definitive place to view real-time UK regulatory disclosures.

You will see a clear and comprehensive search, filter and sort features giving users the ability to:

  • Show only Earnings and News announcements - the default search
  • Show all announcements excluding NAVs & FRNs
  • Show all announcement types
  • See up to 500 stories per page
  • See ‘Most read news’ ticker at the top of the page
  • Select stories by Name/code, source, type, index or sector


about rns

 

News Sources

For information about RNS reach and News Announcements, the news sources available within the Market news section.



The Exchange accepts no responsibility for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds.

You are accessing the London Stock Exchange Annual Report Service powered by PrecisionIR.

The Exchange accepts no responsibility for the content of the reports you are now accessing or for any reliance placed by you or any person on the information contained therein.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds